Browsing Tag
chronic low back pain
2 posts
Mesoblast revenue jumps sevenfold to $120m as Ryoncil turns cell therapy into a commercial business
Mesoblast generated $120.3 million of FY26 revenue, including $115.2 million from Ryoncil, while narrowing its loss 44% and advancing adult GVHD, Duchenne, back pain and heart-failure programmes.
Boston Scientific to buy medical technology company Relievant Medsystems for $850m
Boston Scientific Corporation has struck a definitive deal to purchase Relievant Medsystems for an upfront payment of $850…